EBIO - Eleven Biotherapeutics

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

EBIO - Eleven Biotherapeutics

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ
#1251()/7534

Thu 31'st May 2018

PERIOD 2018-03-05 - 2018-05-31
CHANGE 0.00%
PRICE $3.29
VOLUME
Sell
TREND
Buy

MV LONG
Buy

MV SHORT
Buy

PIVOT
Sell

MACD
Sell

Eleven Biotherapeutics Stock Analysis

Technical stock analysis for Thu 31'st May 2018

Buy candidate since 2018-04-16 Gain 108.23%
Shorts 0.78% ( 2018-04-30 )
Cash 27.1 mill
Loans n/a
Beta 2.85
ROA -32.40

No changes to the price of Eleven Biotherapeutics in the last trading day. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

Trend

Eleven Biotherapeutics lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 216.77% during the next 3 months and, with 90% probability hold a price between $9.18 and $13.24 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

Eleven Biotherapeutics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $3.29 and $2.67. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Wednesday May 30, 2018, which indicates further falls until a new bottom pivot has been found. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock holds a RSI14 at 84 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

Eleven Biotherapeutics finds support from accumulated volume at $3.22.

Support: $3.22 Price: $3.29

Risk

This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.00 between high and low, or 0.00%. For the last week the stock has had a daily average volatility of 0.00%.

Our recommended stoploss: $3.18 (-3.32%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 84 and this increases the risk substantially. There is a sell signal from pivot top found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.

Buy Candidate

Click for Top 5 Buy Candidates

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at


in partnership with
START FREE 5-DAY TRIAL